Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension

  Free Subscription


Articles published in J Perinatol

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    February 2024
  1. HICKS TD, Cameron J, Wang S, Ashrafi A, et al
    Assessing the role of tracheostomy placement in bronchopulmonary dysplasia with pulmonary hypertension.
    J Perinatol. 2024 Feb 5. doi: 10.1038/s41372-024-01881.
    PubMed     Abstract available


    January 2024
  2. MORONTA SC, Bischoff AR, Ryckman KK, Dagle JM, et al
    Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.
    J Perinatol. 2024 Jan 31. doi: 10.1038/s41372-024-01883.
    PubMed     Abstract available


  3. CERVERA SB, Saeed S, Luu TM, Gorgos A, et al
    Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants.
    J Perinatol. 2024 Jan 26. doi: 10.1038/s41372-024-01877.
    PubMed     Abstract available


    October 2023
  4. FIKE CD, Aschner JL, Avachat C, Birnbaum AK, et al
    Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.
    J Perinatol. 2023 Oct 31. doi: 10.1038/s41372-023-01809.
    PubMed     Abstract available


  5. KILMARTIN KC, Al Balushi A, Altit G, Lapointe A, et al
    Impact of persistent pulmonary hypertension and oxygenation on brain injury in neonates with neonatal encephalopathy treated with therapeutic hypothermia.
    J Perinatol. 2023 Oct 23. doi: 10.1038/s41372-023-01805.
    PubMed     Abstract available


  6. BEER L, Rivera BK, Jama W, Slaughter JL, et al
    Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm.
    J Perinatol. 2023 Oct 18. doi: 10.1038/s41372-023-01798.
    PubMed     Abstract available


    August 2023
  7. TIMBERLINE S, Bhatt A, Sunderji S, Tancredi DJ, et al
    Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn.
    J Perinatol. 2023 Aug 25. doi: 10.1038/s41372-023-01762.
    PubMed     Abstract available


  8. ZHU F, Ibarra Rios D, Joye S, Baczynski M, et al
    Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension.
    J Perinatol. 2023 Aug 7. doi: 10.1038/s41372-023-01742.
    PubMed     Abstract available


  9. OSMAN A, Halling C, Crume M, Al Tabosh H, et al
    Meconium aspiration syndrome: a comprehensive review.
    J Perinatol. 2023 Aug 5. doi: 10.1038/s41372-023-01708.
    PubMed     Abstract available


  10. STEFLIK HJ, Wessler LA, Shugart WW, Wagner CL, et al
    Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.
    J Perinatol. 2023;43:1045-1046.
    PubMed    


    February 2023
  11. SHARMA P, Beam K, Levy P, Beam AL, et al
    PD(AI): the role of artificial intelligence in the management of patent ductus arteriosus.
    J Perinatol. 2023;43:257-258.
    PubMed    


    December 2022
  12. MURPHY C, Bussmann N, Staunton D, McCallion N, et al
    The effect of patent ductus arteriosus treatment with paracetamol on pulmonary vascular resistance.
    J Perinatol. 2022;42:1697-1698.
    PubMed    


    November 2022
  13. EL-KHUFFASH A, McNamara PJ, Breatnach C, Bussmann N, et al
    The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1).
    J Perinatol. 2022 Nov 16. pii: 10.1038/s41372-022-01562.
    PubMed     Abstract available


    September 2022
  14. STEFLIK HJ, Brinton DL, Corrigan C, Wagner CL, et al
    Costs associated with acute kidney injury in critically Ill neonates with patent Ductus arteriosus: pediatric health information system (PHIS) analysis.
    J Perinatol. 2022 Sep 7. pii: 10.1038/s41372-022-01499.
    PubMed     Abstract available


    August 2022
  15. DE CARVALHO NUNES G, Wutthigate P, Simoneau J, Dancea A, et al
    The biventricular contribution to chronic pulmonary hypertension of the extremely premature infant.
    J Perinatol. 2022 Aug 25. pii: 10.1038/s41372-022-01497.
    PubMed     Abstract available


  16. PARK L, Donohue L, Lakshminrusimha S, Sankaran D, et al
    Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.
    J Perinatol. 2022 Aug 15. pii: 10.1038/s41372-022-01489.
    PubMed    


    June 2022
  17. AVITABILE CM, Zhang X, Ampah SB, Wang Y, et al
    Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2022 Jun 8. pii: 10.1038/s41372-022-01421.
    PubMed     Abstract available


    May 2022
  18. MEMON N, Griffin I
    Correspondence: "Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort".
    J Perinatol. 2022;42:692.
    PubMed    


    April 2022
  19. GIEN J, Kinsella JP, Behrendt NJ, Zaretsky MV, et al
    Improved survival for infants with severe congenital diaphragmatic hernia.
    J Perinatol. 2022 Apr 23. pii: 10.1038/s41372-022-01397.
    PubMed     Abstract available


  20. CARPENTER RJ, Srdanovic N, Rychlik K, Sen SK, et al
    The association between pulmonary vascular disease and respiratory improvement in infants with type I severe bronchopulmonary dysplasia.
    J Perinatol. 2022 Apr 9. pii: 10.1038/s41372-022-01386.
    PubMed     Abstract available


  21. SALLMON H, Koestenberger M, Avian A, Reiterer F, et al
    Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
    J Perinatol. 2022 Apr 1. pii: 10.1038/s41372-022-01374.
    PubMed     Abstract available


    January 2022
  22. MENDEZ A, Codsi E, Gonzalez Barlatay F, Lapointe A, et al
    Pulmonary hypertension associated with vein of Galen malformation. Fetal cardiac hemodynamic findings and physiological considerations.
    J Perinatol. 2022 Jan 12. pii: 10.1038/s41372-021-01297.
    PubMed     Abstract available


  23. JAIN A, Giesinger RE, Dakshinamurti S, ElSayed Y, et al
    Care of the critically ill neonate with hypoxemic respiratory failure and acute pulmonary hypertension: framework for practice based on consensus opinion of neonatal hemodynamics working group.
    J Perinatol. 2022 Jan 11. pii: 10.1038/s41372-021-01296.
    PubMed     Abstract available


  24. DILLARD J, Pavlek LR, Korada S, Chen B, et al
    Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness.
    J Perinatol. 2022;42:37-44.
    PubMed     Abstract available


    October 2021
  25. NELIN L, Kinsella JP, Courtney SE, Pallotto EK, et al
    Use of inhaled nitric oxide in preterm vs term/near-term neonates with pulmonary hypertension: results of the PaTTerN registry study.
    J Perinatol. 2021 Oct 28. pii: 10.1038/s41372-021-01252.
    PubMed     Abstract available


  26. MAHMOOD B, Murthy K, Rintoul N, Weems M, et al
    Predicting treatment of pulmonary hypertension at discharge in infants with congenital diaphragmatic hernia.
    J Perinatol. 2021 Oct 28. pii: 10.1038/s41372-021-01249.
    PubMed     Abstract available


  27. EVERS PD, Scottoline B, Armsby LB
    Acute right ventricular failure associated with pulmonary hypertension in pediatrics: understanding the hemodynamic profiles.
    J Perinatol. 2021 Oct 18. pii: 10.1038/s41372-021-01231.
    PubMed     Abstract available


  28. YURTTUTAN S, Gullu UU
    Neonatal AKI in late preterm infants with patent ductus arteriosus.
    J Perinatol. 2021;41:2383-2384.
    PubMed    


    May 2021
  29. LOPATA SM, Slaughter JC, Gillam-Krakauer M, Reese J, et al
    The patent ductus arteriosus management debate: it's not over yet.
    J Perinatol. 2021;41:923-925.
    PubMed    


    March 2021
  30. DASGUPTA S, Richardson JC, Aly AM, Jain SK, et al
    Role of functional echocardiographic parameters in the diagnosis of bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2021 Mar 8. pii: 10.1038/s41372-021-01009.
    PubMed     Abstract available


  31. SEABROOK RB, Grover TR, Rintoul N, Weems M, et al
    Treatment of pulmonary hypertension during initial hospitalization in a multicenter cohort of infants with congenital diaphragmatic hernia (CDH).
    J Perinatol. 2021 Mar 1. pii: 10.1038/s41372-021-00923.
    PubMed     Abstract available


    February 2021
  32. ALEEM S, Robbins C, Murphy B, Elliott S, et al
    The use of supplemental hydrocortisone in the management of persistent pulmonary hypertension of the newborn.
    J Perinatol. 2021 Feb 15. pii: 10.1038/s41372-021-00943.
    PubMed     Abstract available


  33. MAT BAH MN, Tan RYH, Razak H, Sapian MH, et al
    Survival and associated risk factors for mortality among infants with persistent pulmonary hypertension of the newborn in Malaysia.
    J Perinatol. 2021 Feb 15. pii: 10.1038/s41372-021-00962.
    PubMed     Abstract available


  34. KESTING AC, Hansmann G, Sallmon H
    Toward a standardized multidisciplinary team approach in preterm infants at-risk for pulmonary hypertension.
    J Perinatol. 2021 Feb 9. pii: 10.1038/s41372-021-00949.
    PubMed    


    January 2021
  35. AGARWAL P, Shankaran S, Laptook AR, Chowdhury D, et al
    Outcomes of infants with hypoxic ischemic encephalopathy and persistent pulmonary hypertension of the newborn: results from three NICHD studies.
    J Perinatol. 2021 Jan 6. pii: 10.1038/s41372-020-00905.
    PubMed     Abstract available


    September 2020
  36. GONZALEZ A, Bancalari A, Osorio W, Luco M, et al
    Correction: Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial.
    J Perinatol. 2020 Sep 7. pii: 10.1038/s41372-020-00806.
    PubMed     Abstract available


    August 2020
  37. SAHNI M, Yeboah B, Das P, Shah D, et al
    Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2020 Aug 18. pii: 10.1038/s41372-020-00788.
    PubMed     Abstract available


  38. HEBERT A, Drolet C, Altit G, Villeneuve A, et al
    Management of chronic pulmonary hypertension in neonates with bronchopulmonary dysplasia: perspectives of neonatologists with hemodynamic expertise and pediatric cardiologists.
    J Perinatol. 2020 Aug 16. pii: 10.1038/s41372-020-00791.
    PubMed    


  39. GONZALEZ A, Bancalari A, Osorio W, Luco M, et al
    Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial.
    J Perinatol. 2020 Aug 13. pii: 10.1038/s41372-020-00777.
    PubMed     Abstract available


    July 2020
  40. BISCHOFF AR, Giesinger RE, Bell EF, McNamara PJ, et al
    Precision medicine in neonatal hemodynamics: need for prioritization of mechanism of illness and defining population of interest.
    J Perinatol. 2020 Jul 27. pii: 10.1038/s41372-020-0741.
    PubMed    


    June 2020
  41. GRIFFITHS M, Yang J, Everett AD, Jennings JM, et al
    Correction: Endostatin and ST2 are predictors of pulmonary hypertension disease course in infants.
    J Perinatol. 2020 Jun 2. pii: 10.1038/s41372-020-0700.
    PubMed     Abstract available


    May 2020
  42. KEUSTERS L, Purna J, Deshpande P, Mertens L, et al
    Clinical validity of systemic arterial steal among extremely preterm infants with persistent patent ductus arteriosus.
    J Perinatol. 2020 May 11. pii: 10.1038/s41372-020-0663.
    PubMed     Abstract available


  43. GRIFFITHS M, Yang J, Everett AD, Jennings JM, et al
    Endostatin and ST2 are predictors of pulmonary hypertension disease course in infants.
    J Perinatol. 2020 May 4. pii: 10.1038/s41372-020-0671.
    PubMed     Abstract available


    April 2020
  44. OSMAN A
    Contributions of Ibn Alnafis to the correct understanding of the circulation.
    J Perinatol. 2020;40:688.
    PubMed    


  45. XIONG T, Kulkarni M, Gokulakrishnan G, Shivanna B, et al
    Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
    J Perinatol. 2020;40:607-615.
    PubMed     Abstract available


    January 2020
  46. NAEEM B, Ayub A, Aly AM, Malloy MH, et al
    Urinary NT-proBNP as a potential noninvasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study.
    J Perinatol. 2020 Jan 7. pii: 10.1038/s41372-019-0581.
    PubMed     Abstract available


    November 2019
  47. SHETH S, Goto L, Bhandari V, Abraham B, et al
    Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
    J Perinatol. 2019 Nov 13. pii: 10.1038/s41372-019-0549.
    PubMed     Abstract available


  48. SHARMA J, Sherman A, Rimal A, Haney B, et al
    Neonatal respiratory extracorporeal membrane oxygenation and primary diagnosis: trends between two decades.
    J Perinatol. 2019 Nov 7. pii: 10.1038/s41372-019-0547.
    PubMed     Abstract available


    March 2019
  49. BREATNACH CR, Bussmann N, Smith A, Levy P, et al
    Cardiac mechanics in infants with Down syndrome in the early neonatal period.
    J Perinatol. 2019 Mar 25. pii: 10.1038/s41372-019-0354.
    PubMed     Abstract available


  50. AGARWAL P, Altinok D, Desai J, Shanti C, et al
    In-hospital outcomes of neonates with hypoxic-ischemic encephalopathy receiving extracorporeal membrane oxygenation.
    J Perinatol. 2019 Mar 6. pii: 10.1038/s41372-019-0345.
    PubMed     Abstract available


  51. GAFFAR S, Ellini AR, Ahmad I, Chen Y, et al
    Left ventricular cardiac output is a reliable predictor of extracorporeal life support in neonates with congenital diaphragmatic hernia.
    J Perinatol. 2019 Mar 5. pii: 10.1038/s41372-019-0348.
    PubMed     Abstract available


    October 2018
  52. MANJA V, Guyatt G, Lakshminrusimha S, Jack S, et al
    Factors influencing decision making in neonatology: inhaled nitric oxide in preterm infants.
    J Perinatol. 2018 Oct 23. pii: 10.1038/s41372-018-0258.
    PubMed     Abstract available


  53. COLLURA CA, Mara KC, Weaver AL, Clark RH, et al
    Outcomes of early inhaled nitric oxide use in premature African American neonates.
    J Perinatol. 2018 Oct 1. pii: 10.1038/s41372-018-0232.
    PubMed     Abstract available


    May 2018
  54. MCANDREW S, Acharya K, Nghiem-Rao TH, Leuthner S, et al
    NICU management and outcomes of infants with trisomy 21 without major anomalies.
    J Perinatol. 2018 May 25. pii: 10.1038/s41372-018-0136.
    PubMed     Abstract available


  55. PAPADHIMA I, Louis D, Purna J, Deshpande P, et al
    Targeted neonatal echocardiography (TNE) consult service in a large tertiary perinatal center in Canada.
    J Perinatol. 2018 May 22. pii: 10.1038/s41372-018-0130.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.